(c) 2024 PillSync.com

gabapentin 300 mg

1 INDICATIONS AND USAGE Gabapentin is indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin is indicated for: Postherpetic neuralgia in adults ( 1 ) Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 )

Sun Pharmaceutical Industries Limited


2 months ago CAPSULE YELLOW 138 138 gabapentin 300 mg

CAPSULE YELLOW 138 138

2 months ago CAPSULE YELLOW 138 138 gabapentin 300 mg

138 138 CAPSULE YELLOW

16 HOW SUPPLIED/STORAGE AND HANDLING

GABAPENTIN capsules, USP are supplied as follows: 100 mg capsules: white hard gelatin capsules printed with “137” on cap and body; available in: Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-137-02 Non Child Resistant Cap -----------------------------------NDC 62756-137-03 Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05 Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04 Unit dose 50's: ------------------------------------------------------------------NDC 62756-137-01 300 mg capsules: yellow hard gelatin capsules printed with “138” on cap and body; available in: Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ----------------------------------NDC 62756-138-03 Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05 Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04 Unit dose 50's: ------------------------------------------------------------------NDC 62756-138-01 400 mg capsules: orange hard gelatin capsules printed with “139” on cap and body; available in: Bottles of 100: Child Resistant Cap -----------------------------------------NDC 62756-139-02 Non Child Resistant Cap ----------------------------------NDC 62756-139-03 Bottles of 500: Non Child Resistant Cap ------------------------------------NDC 62756-139-05 Bottles of 1000: Non Child Resistant Cap ------------------------------------NDC 62756-139-04 Unit dose 50's: -----------------------------------------------------------------NDC 62756-139-01

GABAPENTIN tablets, USP are supplied as follows: 600 mg tablets: white to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side (“2” on one side of score line and “02” on other side of score line), available in: Bottles of 100: Child Resistant Cap -----------------------------------------NDC 62756-202-01 Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03 800 mg tablets; white to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side (“2” on one side of score line and “04” on other side of score line), available in: Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03 Storage Store at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [see USP Controlled Room Temperature].


More pills like CAPSULE 138 138

Related Pills

gabapentin 100 MG Oral Capsule

sun pharmaceutical industries, inc.

gabapentin capsule gabapentin tablet film coated

sun pharmaceutical industries limited












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site